Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,939 total articles
Fiserv trades at single-digit P/E and mid-single EV/EBITDA despite low liquidity and a heavy debt load. The business generates solid free cash flow ($4.13B trailing), and a reorganized capital structure plus activist-driven changes create a plausible rerating path. This is a directional long with an explicit stop — not a buy-and-forget — suited to …
BDRAF is trading near short-term technical support while short interest and short-volume dynamics create asymmetric upside potential. With moving averages converging, improving momentum, and a narrative shift toward cash flow generation, we lay out an actionable long trade with clear entry, stop and target levels and a 180‑day time horizon.
<p>Cohu is a smaller-cap maker of back-end semiconductor test and handling equipment that is beginning to show concrete revenue and design-win signals tied to AI and high-bandwidth memory (HBM). The stock still trades well below its June highs despite a strong YoY revenue run, leaving an asymmetric risk/reward for patient buyers. This trade idea la…
ZIM trades well below a $35 per-share all-cash bid from Hapag-Lloyd. Weak freight rates and Q1 pain have pressured the stock to $24.61, creating a visible arbitrage spread. This trade targets the deal price while using a clear stop and a time-bound horizon tied to the expected close window.
IBM plunged after a profit warning tied to customers shifting spend into servers, storage and memory. The reaction ignored IBM's cash generation, reasonable valuation (P/E ~18.7), dividend yield and durable hybrid-cloud position. This trade targets a rebound toward $280 with a disciplined stop at $196.
Guidewire has already priced much of the cloud migration story into its shares. Recent results and deals show durable subscription momentum, but the bigger optionality is cross-sell of analytics, AI-enabled services and a platform layer that can lift margins and ARR multiple. This trade idea buys the setup near $149.46 with a mid- and long-term tar…
Archer-Daniels-Midland (ADM) looks poised to resume an upward move driven by improving processing margins, resilient global food demand, and disciplined capital allocation. This note lays out a clear trade idea with entry, stop, targets and a timeline tied to fundamental and seasonal catalysts.
JAKKS Pacific's recent licensing push into anime, paired with improving margins, a debt-free balance sheet, and positive free cash flow, creates a timely swing trade setup. The stock is trading near its 52-week high but still cheap on EV/sales and enterprise value metrics. Our plan targets a disciplined entry at $24.57, a stop at $21.00, and a $30.…
Iovance (IOVA) has been beaten down over the past five years but is showing signs of stabilization: $Amtagvi is driving 60.6% revenue growth, liquidity metrics look reasonable, and technicals show bullish momentum. I upgrade to Buy with a clear entry at $4.79, a $3.60 stop loss, and a $9.00 target on a swing-oriented plan, but this remains a high-r…
Eos Energy plunged into oversold territory after a volatile June-July that included a rights offering and heavy shorting. Preliminary Q2 revenue of $68-69M and an $807M backlog materially de-risk near-term growth. At a $1.42B market cap and $1.76B enterprise value, the stock is pricing execution risk; the technicals, short interest and liquidity im…
Osisko Development (ODV) has materially de-risked Cariboo’s financing with a US$225M convertible note package and a prior US$125M equity raise. The stock still trades well below the conversion and offering prices, leaving room for a sentiment-driven rerate as project execution milestones arrive. This trade idea lays out an actionable long with entr…
Advanced Micro Devices (AMD) sits squarely in the crosshairs of the agentic AI-driven server refresh. The stock has pulled back from its June highs and offers a tradeable entry into what could be another leg higher if August earnings confirm accelerating server CPU demand. This is a mid-term swing trade designed to capture the post-earnings re-rati…
U.S. Bancorp (USB) looks like a pragmatic value buy: a $99.6B market cap bank trading at ~13x earnings and 1.66x book, growing loans, and paying a $2.08 annual dividend (3%+ yield). Initiate a long position on a controlled pullback; target a re-rating to a higher P/B while collecting yield along the way.
Tyler Technologies is down big from its 2025 highs, but the business — mission-critical software for local governments — is structurally defensive and cash generative. This trade targets a rebound tied to cloud conversion progress, continued recurring revenue growth, and margin expansion as on-prem customers migrate. Entry, stop and target are laid…
Broadcom is riding a widening AI infrastructure moat driven by hyperscaler custom chips, networking, and a growing software franchise. With a $1.82T market cap, strong free cash flow and an Apple commitment that reduces concentration risk, AVGO looks like a tactical buy into a mid-term rebound. This idea lays out an entry at $381.78, a stop at $350…
Abivax's obefazimod showed durable Phase 3 efficacy in ulcerative colitis and the company secured a heavily subscribed $800M ADS offering, shoring up the balance sheet. The market overreacted to safety signal noise in June; the data and recent financing reset the risk/reward. I initiate a buy with an entry at $137.60, a stop loss at $115.00 and a t…
Nvidia ($208.81) is richly priced, operationally strong but momentum-sensitive. TSMC's recent earnings tone — weaker demand and caution on AI inventory — is a warning shot for Nvidia's data-center growth cadence. For traders who agree the near-term demand trajectory has been overstated, a tactical short with tight sizing and clear stops offers an a…
Ardmore Shipping (ASC) trades at a reasonable multiple with a $657.7m market cap, a 4.05% yield, and clear operational catalysts that support earnings durability beyond short-term tanker rate spikes. This trade targets a rebound toward the 52-week high while managing downside with a conservative stop. Hold for the long term (180 trading days) to ca…
Lionsgate's share price has lagged peers, yet the company still controls valuable content franchises and a growing streaming footprint. A credible strategic buyer or a corporate simplification push could re-rate the stock. We lay out a long trade with clear entry, stop and targets, and a view on catalysts and risks.
Richardson Electronics (RELL) has a string of tangible commercial partnerships and improving quarterly results that together justify a bullish, actionable trade. The company's expanding presence in battery energy storage, silicon carbide power semiconductors and contract manufacturing give it multiple near-term revenue levers. Technicals and short …
SLB is trading around $47.50 with a $71 billion market cap, attractive free cash flow and a Digital segment that management and multiple commentators peg above $1 billion in recurring revenue. The stock has pulled back with the oil price correction, RSI around 40 and short interest modest. We think investors can take a long position at $47.50, targ…
Nvidia’s CEO putting his personal capital into the stock is a high-conviction signal we can trade. Take a tactical long with clear entry, stop and target levels: entry $1200.00, initial target $1400.00, stop $1000.00. Time the position for a mid-term swing (45 trading days) with an optional hold to 180 trading days if momentum and earnings reinforc…
SK hynix just listed on Nasdaq, raised $26.5 billion in a U.S. ADR offering to pre-fund HBM and DRAM capacity, and controls a dominant share of HBM — yet the ADR trades like a cyclical commodity name. The combination of contracted demand from hyperscalers, a funded expansion for AI-grade memory, and a still-reasonable forward multiple argues for a …
Mosaic (MOS) looks materially undervalued relative to asset replacement and near-term market catalysts. The stock trades at roughly 0.62x book and an enterprise value to EBITDA of about 6.9, while fertilizer supply disruptions and a new rare-earths project create optionality. We upgrade MOS to a long trade with a clear entry, stop and target and a …
Vir (VIR) is a clinical-stage immunology company trading at a market cap of roughly $1.62B with a deep pipeline in hepatitis delta (HDV) and a PSMA-targeted T-cell engager in oncology. The company carries meaningful cash on the balance sheet, an imminent Phase 3 HDV readout in Q4 2026, and pivotal oncology milestones in 2027. This trade idea lays o…
